KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Chemed (CHE) EBITDA Margin: 2009-2024

Historic EBITDA Margin for Chemed (CHE) over the last 16 years, with FY2024 value amounting to 17.25%.

  • Chemed's EBITDA Margin fell 32200.0% to 14.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.02%, marking a year-over-year decrease of 15000.0%. This contributed to the annual value of 17.25% for FY2024, which is 400.0% down from last year.
  • Latest data reveals that Chemed reported EBITDA Margin of 17.25% as of FY2024, which was down 400.0% from 17.28% recorded in FY2023.
  • Over the past 5 years, Chemed's EBITDA Margin peaked at 2596.88% during FY2020, and registered a low of 17.25% during FY2024.
  • In the last 5 years, Chemed's EBITDA Margin had a median value of 18.33% in 2021 and averaged 533.63%.
  • As far as peak fluctuations go, Chemed's EBITDA Margin tumbled by -25785500bps in 2021, and later surged by 600bps in 2022.
  • Over the past 5 years, Chemed's EBITDA Margin (Annual) stood at 2596.88% in 2020, then crashed by -99bps to 18.33% in 2021, then increased by 0bps to 18.39% in 2022, then dropped by -6bps to 17.28% in 2023, then decreased by 0bps to 17.25% in 2024.
  • Its EBITDA Margin was 17.25% in FY2024, compared to 17.28% in FY2023 and 18.39% in FY2022.